Copyright (c) 2009 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=achnLatest Financial News for Achillion Pharmaceuticals, Inc.en-usWed, 23 Dec 2009 21:57:45 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/barrons/rss/SIG=11v577tks/*http%3A//online.barrons.com/article/SB126152060280202043.html?ru=yahoo&mod=yahoobarronsStocks in the Spotlight Wednesday Cintas fell. Compugen, Achillion and pSivida all rose.yahoo_finance/1450573989Wed, 23 Dec 2009 21:57:45 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12rl06aa2/*http%3A//www.marketwatch.com/news/story/drug-stocks-sluggish-achillion-psivida/story.aspx?guid=%7B6B710D73%2D148C%2D4DC9%2D9720%2DC7675B8797E3%7D&siteid=yhoofyahoo_finance/3196254775Wed, 23 Dec 2009 18:33:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12kt2smnb/*http%3A//www.marketwatch.com/news/story/drug-stocks-trade-higher-sanofi/story.aspx?guid=%7B6B710D73%2D148C%2D4DC9%2D9720%2DC7675B8797E3%7D&siteid=yhoofDrug- and biotech-sector benchmarks move higher in early action, with Sanofi-Aventis and Bristol-Myers Squibb among the issues holding investors' attention.yahoo_finance/374582738Wed, 23 Dec 2009 15:51:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12ue6vemp/*http%3A//www.thestreet.com/_yahoo/story/10651913/1/achillion-psivida-early-volume-plays.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/645320254Wed, 23 Dec 2009 14:31:56 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/ud?s=ACHNyahoo_finance/1614178843Wed, 23 Dec 2009 07:15:26 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091222/achn8-k.htmlyahoo_finance/242879470Tue, 22 Dec 2009 21:15:14 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ts/091221/10650225.html?.v=1Biogen Idec CEO and President James Mullen sells $7.4 million worth.yahoo_finance/602537473Mon, 21 Dec 2009 18:28:51 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091217/us_anadys_pharmaceuticals_study.html?.v=1Anadys Pharmaceuticals Inc. said Thursday its experimental hepatitis C drug is meeting key goals in a midstage clinical trial.yahoo_finance/3543586607Thu, 17 Dec 2009 16:15:48 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091217/180502.html?.v=1DALLAS -- BeaconEquity.com announces an investment report featuring Achillion Pharmaceuticals Inc. . The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.yahoo_finance/2248747196Thu, 17 Dec 2009 11:50:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12ind462m/*http%3A//online.wsj.com/article/SB10001424052748703581204574600501770957952.html?ru=yahoo&mod=yahoo_hsyahoo_finance/3344176513Thu, 17 Dec 2009 02:57:52 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091216/us_movers_roundup_darden_restaurants.html?.v=2Shares of restaurant owner Darden Restaurants Inc., which operates Olive Garden, Red Lobster and Longhorn Steakhouse, climbed after an analyst upgraded the stock.yahoo_finance/676943680Wed, 16 Dec 2009 22:46:53 Etc/GMThttp://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12ico94j2/*http%3A//online.wsj.com/article/SB10001424052748704541004574600480537232924.html?ru=yahoo&mod=yahoo_hsyahoo_finance/555929642Wed, 16 Dec 2009 22:15:19 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091216/us_wall_street_stocks.html?.v=4The following stocks were among those that moved substantially or traded heavily Wednesday on the New York Stock Exchange and the Nasdaq Stock Market:yahoo_finance/1328049364Wed, 16 Dec 2009 21:55:20 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091216/us_achillion_pharmaceuticals_mover.html?.v=1Shares of Achillion Pharmaceuticals Inc. surged Wednesday after the company said its hepatitis C drug candidate showed positive "proof-of-concept" results, while meeting safety and tolerability goals in an early-stage study.yahoo_finance/3423123691Wed, 16 Dec 2009 19:33:53 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091216/180446.html?.v=1CALGARY, Alberta -- Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on Achillion Pharmaceuticals, Inc. . Emerging Stock Report is currently offering a complimentary trial subscription to the investment community.yahoo_finance/3968696974Wed, 16 Dec 2009 16:47:48 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh02164_2009-12-16_16-37-29_sge5bf0ho_newsml&rpc=44&type=marketsNewsyahoo_finance/3501159521Wed, 16 Dec 2009 16:37:29 Etc/GMThttp://us.rd.yahoo.com/finance/external/cbsm/rss/SIG=12mlgfs96/*http%3A//www.marketwatch.com/news/story/drug-stocks-rise-achillion-sanofi/story.aspx?guid=%7B08D39E49%2D73EB%2D4AD9%2D9AFC%2D0D78ED492B41%7D&siteid=yhoofyahoo_finance/3869255917Wed, 16 Dec 2009 15:36:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12tfedgli/*http%3A//www.thestreet.com/_yahoo/story/10646927/1/achillion-emcore-early-volume-plays.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1083834771Wed, 16 Dec 2009 12:15:44 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/pz/091215/180386.html?.v=1yahoo_finance/4033371968Tue, 15 Dec 2009 22:39:24 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091215/achn8-k.htmlyahoo_finance/2644888408Tue, 15 Dec 2009 20:36:31 Etc/GMT